BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37905045)

  • 1. Systematic perturbations of SETD2, NSD1, NSD2, NSD3 and ASH1L reveals their distinct contributions to H3K36 methylation.
    Shipman GA; Padilla R; Horth C; Hu B; Bareke E; Vitorino FN; Gongora JM; Garcia BA; Lu C; Majewski J
    bioRxiv; 2023 Oct; ():. PubMed ID: 37905045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional specificity of H3K36 methylation.
    Lam UTF; Tan BKY; Poh JJX; Chen ES
    Epigenetics Chromatin; 2022 May; 15(1):17. PubMed ID: 35581654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis.
    Gameiro SF; Ghasemi F; Zeng PYF; Mundi N; Howlett CJ; Plantinga P; Barrett JW; Nichols AC; Mymryk JS
    Infect Agent Cancer; 2021 Feb; 16(1):13. PubMed ID: 33588906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape.
    Weinberg DN; Papillon-Cavanagh S; Chen H; Yue Y; Chen X; Rajagopalan KN; Horth C; McGuire JT; Xu X; Nikbakht H; Lemiesz AE; Marchione DM; Marunde MR; Meiners MJ; Cheek MA; Keogh MC; Bareke E; Djedid A; Harutyunyan AS; Jabado N; Garcia BA; Li H; Allis CD; Majewski J; Lu C
    Nature; 2019 Sep; 573(7773):281-286. PubMed ID: 31485078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2.
    Eram MS; Kuznetsova E; Li F; Lima-Fernandes E; Kennedy S; Chau I; Arrowsmith CH; Schapira M; Vedadi M
    Biochim Biophys Acta; 2015 Sep; 1850(9):1842-8. PubMed ID: 26002201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of NSD2 and NSD3 in overgrowth syndromes.
    Douglas J; Coleman K; Tatton-Brown K; Hughes HE; Temple IK; Cole TR; Rahman N;
    Eur J Hum Genet; 2005 Feb; 13(2):150-3. PubMed ID: 15483650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer.
    Xiong Q; Zhou Y; Zhang S; Zhang Y; Xu Y; Yang Y; Zhou C; Zeng Z; Han J; Zhu Q
    Cancer Med; 2023 May; 12(9):10961-10978. PubMed ID: 37062069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSD1-deposited H3K36me2 directs de novo methylation in the mouse male germline and counteracts Polycomb-associated silencing.
    Shirane K; Miura F; Ito T; Lorincz MC
    Nat Genet; 2020 Oct; 52(10):1088-1098. PubMed ID: 32929285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L.
    Morishita M; Mevius D; di Luccio E
    BMC Struct Biol; 2014 Dec; 14():25. PubMed ID: 25494638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.
    Topchu I; Pangeni RP; Bychkov I; Miller SA; Izumchenko E; Yu J; Golemis E; Karanicolas J; Boumber Y
    Cell Mol Life Sci; 2022 May; 79(6):285. PubMed ID: 35532818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases.
    Li W; Tian W; Yuan G; Deng P; Sengupta D; Cheng Z; Cao Y; Ren J; Qin Y; Zhou Y; Jia Y; Gozani O; Patel DJ; Wang Z
    Nature; 2021 Feb; 590(7846):498-503. PubMed ID: 33361816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The H3.3 G34W oncohistone mutation increases K36 methylation by the protein lysine methyltransferase NSD1.
    Bröhm A; Schoch T; Grünberger D; Khella MS; Schuhmacher MK; Weirich S; Jeltsch A
    Biochimie; 2022 Jul; 198():86-91. PubMed ID: 35341929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, Activity and Function of the NSD3 Protein Lysine Methyltransferase.
    Rathert P
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSD1 deposits histone H3 lysine 36 dimethylation to pattern non-CG DNA methylation in neurons.
    Hamagami N; Wu DY; Clemens AW; Nettles SA; Gabel HW
    bioRxiv; 2023 Feb; ():. PubMed ID: 36824816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The T1150A cancer mutant of the protein lysine dimethyltransferase NSD2 can introduce H3K36 trimethylation.
    Khella MS; Schnee P; Weirich S; Bui T; Bröhm A; Bashtrykov P; Pleiss J; Jeltsch A
    J Biol Chem; 2023 Jun; 299(6):104796. PubMed ID: 37150325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NSD1 deposits histone H3 lysine 36 dimethylation to pattern non-CG DNA methylation in neurons.
    Hamagami N; Wu DY; Clemens AW; Nettles SA; Li A; Gabel HW
    Mol Cell; 2023 May; 83(9):1412-1428.e7. PubMed ID: 37098340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
    Wang GG; Cai L; Pasillas MP; Kamps MP
    Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions.
    Ettel M; Zhao L; Schechter S; Shi J
    Pathology; 2019 Jun; 51(4):392-398. PubMed ID: 31060750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation.
    Rajagopalan KN; Chen X; Weinberg DN; Chen H; Majewski J; Allis CD; Lu C
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancers and the NSD family of histone lysine methyltransferases.
    Morishita M; di Luccio E
    Biochim Biophys Acta; 2011 Dec; 1816(2):158-63. PubMed ID: 21664949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.